Vesco Vitamins unveils supplement capsules
The comapy began research on the capsule in March 2011 and it is said to be suitable for vegetarians. The first product in the On Task range, Cherry
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).
PrognoCIS enables physicians to qualify for federal funding to assist with EMR costs. PrognoCIS EMR system features system-level and encounter-level dashboards and helps track and monitor the customer’s